Moreover, alterations to signaling molecules upstream of these transcription factors, including CSF1R [44], PI3Kγ [45], or the SRC kinase HCK [23,25,26,46], are currently exploited to limit alternative macrophage polarization as adjuvant therapy for cancer. This evidence concerns the gene CSF1R and cancer.